STOCKSCREENR
Log In

APS.TO

TSX

Aptose Biosciences Inc.

$2.22+0.03(+1.37%)Mkt Cap: $5.67M

Key Stats

Market Cap

$5.67M

P/E Ratio

2.36

EPS

$0.94

Dividend Yield

0.00%

52-Week Range

$1.02 — $5.80

Volume

6.11K

Avg Volume

4.21K

Beta

0.40

Valuation

P/E (TTM)

2.36

Forward P/E

—

PEG Ratio

0.03

P/S (TTM)

9.64

P/B (TTM)

-0.22

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

1.24%

ROA (TTM)

-2.23%

ROIC

—

Gross Margin

0.50%

Operating Margin

41.08%

Net Margin

—

Debt/Equity

-0.02

Current Ratio

0.53

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+0.42%

EPS Growth (5Y)

+0.18%

Sales Growth (3Y)

+0.00%

Sales Growth (5Y)

+0.00%

EPS Est (This Year)

$-5.58

EPS Est (Next Year)

$-16.00

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.24

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

2.55M

Float

2.04M

Free Float %

79.75%

About

Sector

Healthcare

Industry

Biotechnology

Country

CA

Exchange

TSX

IPO Date

1996-04-25

Employees

13

CEO

William G. Rice

Index Membership

—

Website

https://www.aptose.com

Aptose Biosciences Inc. (APS.TO) is a healthcare company in the biotechnology industry listed on the TSX. With a market capitalization of $5.67M, a P/E ratio of 2.36, APS.TO is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare APS.TO against other stocks using dozens of fundamental and technical filters.

Similar Stocks

IBO.V

Universal Ibogaine Inc.

$0.01

-50.00%

$1.56M

PASG

Passage Bio, Inc.

$7.37

-3.53%

$23.64M

PHIO

Phio Pharmaceuticals Corp.

$1.27

+0.79%

$14.75M

IMRN

Immuron Limited

$0.75

-5.19%

$4.83M

ASBP

Aspire Biopharma Holdings, Inc.

$0.88

-10.21%

$3.03M

BRTX

BioRestorative Therapies, Inc.

$0.25

-12.40%

$2.24M

Frequently Asked Questions

What is Aptose Biosciences Inc.'s P/E ratio?

Aptose Biosciences Inc. (APS.TO) has a trailing twelve-month (TTM) P/E ratio of 2.36. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Aptose Biosciences Inc. pay a dividend?

No, Aptose Biosciences Inc. (APS.TO) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Aptose Biosciences Inc.'s market cap?

Aptose Biosciences Inc. (APS.TO) has a market capitalization of $5.67 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.